A recently granted patent (Publication Number: US11884928B2) discloses a method for modifying a target site in a Kluyveromyces host cell genome. The method involves reducing non-homologous end joining ...

Click to share on X (Opens in new window) X Click to share on Facebook (Opens in new window) Facebook As I reach the end of my time here at the University, more and more of my classes as an engineer ...

Can you patent a human gene? Alexi Horowitz-Ghazi of our Planet Money team has the story of how this question wound up at the U.S. Supreme Court and how it raised an even more fundamental question - ...

Not so long ago, if you asked someone about the US Patent and Trademark Office’s practice of granting patents on human genes, you’d probably get one of two responses. Biotechnology insiders would ...

The patents on the BRCA genes are particularly broad and offensive. The PTO has granted Myriad Genetics, a private biotechnology company based in Utah, patents on both the BRCA1 and BRCA2 genetic ...

A recent case suggests that the attitude of Indian courts toward genetically modified organisms may be shifting. Earlier this year, the Supreme Court of India set aside an order of the division bench ...

This is a preview. Log in through your library . Publisher Information BRILL, founded in 1683, is a publishing house with a strong international focus. BRILL is renowned for its publications in the ...

Amyris has patented a method for genetically engineering Kluyveromyces to produce and secrete antibodies. The method involves modifying the host cell genome, reducing NHEJ activity, and integrating ...